141 related articles for article (PubMed ID: 24559832)
1. The use of complementary and alternative medicine in patients with multiple sclerosis: a longitudinal study.
Kochs L; Wegener S; Sühnel A; Voigt K; Zettl UK
Complement Ther Med; 2014 Feb; 22(1):166-72. PubMed ID: 24559832
[TBL] [Abstract][Full Text] [Related]
2. How frequently do patients with multiple sclerosis use complementary and alternative medicine?
Apel A; Greim B; Zettl UK
Complement Ther Med; 2005 Dec; 13(4):258-63. PubMed ID: 16338196
[TBL] [Abstract][Full Text] [Related]
3. Coping behavior in multiple sclerosis-complementary and alternative medicine: A cross-sectional study.
Rommer PS; König N; Sühnel A; Zettl UK
CNS Neurosci Ther; 2018 Sep; 24(9):784-789. PubMed ID: 29635832
[TBL] [Abstract][Full Text] [Related]
4. Use of therapies other than disease-modifying agents, including complementary and alternative medicine, by patients with multiple sclerosis: a survey study.
Stoll SS; Nieves C; Tabby DS; Schwartzman R
J Am Osteopath Assoc; 2012 Jan; 112(1):22-8. PubMed ID: 22302743
[TBL] [Abstract][Full Text] [Related]
5. Why physicians need to look more closely at the use of complementary and alternative medicine by multiple sclerosis patients.
Pucci E; Cartechini E; Taus C; Giuliani G
Eur J Neurol; 2004 Apr; 11(4):263-7. PubMed ID: 15061828
[TBL] [Abstract][Full Text] [Related]
6. Differences between users and non-users of complementary and alternative medicine among people with multiple sclerosis in Denmark: a comparison of descriptive characteristics.
Skovgaard L; Nicolajsen PH; Pedersen E; Kant M; Fredrikson S; Verhoef M; Meyrowitsch D
Scand J Public Health; 2013 Jul; 41(5):492-9. PubMed ID: 23548494
[TBL] [Abstract][Full Text] [Related]
7. Frequency of current utilisation of complementary and alternative medicine by patients with multiple sclerosis.
Apel A; Greim B; König N; Zettl UK
J Neurol; 2006 Oct; 253(10):1331-6. PubMed ID: 16786211
[TBL] [Abstract][Full Text] [Related]
8. Use and users of complementary and alternative medicine among people with multiple sclerosis in Denmark.
Skovgaard L
Dan Med J; 2016 Jan; 63(1):B5159. PubMed ID: 26726906
[TBL] [Abstract][Full Text] [Related]
9. Use of complementary and alternative medicine in patients with multiple sclerosis in Germany.
Gotta M; Mayer CA; Huebner J
Complement Ther Med; 2018 Feb; 36():113-117. PubMed ID: 29458916
[TBL] [Abstract][Full Text] [Related]
10. The role of complementary and alternative medicine in therapy of multiple sclerosis.
Kes VB; Cesarik M; Matovina LZ; Zavoreo I; Corić L; Drnasin S; Demarin V
Acta Clin Croat; 2013 Dec; 52(4):464-71. PubMed ID: 24696997
[TBL] [Abstract][Full Text] [Related]
11. Complementary and Alternative Medicine Usage by Multiple Sclerosis Patients: Results from a Prospective Clinical Study.
Kim S; Chang L; Weinstock-Guttman B; Gandhi S; Jakimovski D; Carl E; Zivadinov R; Ramanathan M
J Altern Complement Med; 2018 Jun; 24(6):596-602. PubMed ID: 29498537
[TBL] [Abstract][Full Text] [Related]
12. The use of complementary and alternative therapies by people with multiple sclerosis.
Page SA; Verhoef MJ; Stebbins RA; Metz LM; Levy JC
Chronic Dis Can; 2003; 24(2-3):75-9. PubMed ID: 12959678
[TBL] [Abstract][Full Text] [Related]
13. The perceived benefit and satisfaction from conventional and complementary and alternative medicine (CAM) in people with multiple sclerosis.
Shinto L; Yadav V; Morris C; Lapidus JA; Senders A; Bourdette D
Complement Ther Med; 2005 Dec; 13(4):264-72. PubMed ID: 16338197
[TBL] [Abstract][Full Text] [Related]
14. Complementary and alternative medicine use for arthritis pain in 2 Chicago community areas.
Feinglass J; Lee C; Rogers M; Temple LM; Nelson C; Chang RW
Clin J Pain; 2007; 23(9):744-9. PubMed ID: 18075399
[TBL] [Abstract][Full Text] [Related]
15. A review of complementary and alternative medicine (CAM) by people with multiple sclerosis.
Olsen SA
Occup Ther Int; 2009; 16(1):57-70. PubMed ID: 19222053
[TBL] [Abstract][Full Text] [Related]
16. Complementary and alternative medicine and multiple sclerosis.
Bowling AC
Neurol Clin; 2011 May; 29(2):465-80. PubMed ID: 21439454
[TBL] [Abstract][Full Text] [Related]
17. The Manitoba Inflammatory Bowel Disease Cohort Study: a prospective longitudinal evaluation of the use of complementary and alternative medicine services and products.
Rawsthorne P; Clara I; Graff LA; Bernstein KI; Carr R; Walker JR; Ediger J; Rogala L; Miller N; Bernstein CN
Gut; 2012 Apr; 61(4):521-7. PubMed ID: 21836028
[TBL] [Abstract][Full Text] [Related]
18. Predictors of complementary and alternative medicine use in chronic pain patients.
Ndao-Brumblay SK; Green CR
Pain Med; 2010 Jan; 11(1):16-24. PubMed ID: 20447293
[TBL] [Abstract][Full Text] [Related]
19. Complementary and alternative medicine in multiple sclerosis: a questionnaire-based study.
Podlecka-Piętowska A; Sugalska M; Janiszewska K; Wall-Szczech A; Cyganek A; Szejko N; Zakrzewska-Pniewska B
Neurol Neurochir Pol; 2022; 56(5):428-434. PubMed ID: 36069151
[TBL] [Abstract][Full Text] [Related]
20. Complementary and alternative medicine use in patients with gout: a longitudinal observational study.
Chan E; House ME; Petrie KJ; Horne A; Taylor WJ; Dalbeth N
J Clin Rheumatol; 2014 Jan; 20(1):16-20. PubMed ID: 24356480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
